Opendata, web and dolomites

TRILLIO SIGNED

TRILLIO, a porTable pRescription assistant Improving heaLth of Europeans citizens by increasing therapeutic adherence in eLderly people and in patIents affected by chrOnic diseases

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 TRILLIO project word cloud

Explore the words cloud of the TRILLIO project. It provides you a very rough idea of what is the project "TRILLIO" about.

clock    poor    treatment    visual    tested    care    former    really    feasibility       population    familiar    treatments    share    comanda    hospitals    medical    notification    button    site    players    endorsement    purpose    chronic    112    pharmaceutical    minutes    received    elderly    distributing    causes    carlo    display    follows    off    expenditure    provider    suitable    2023    source    demo    drug    automatically    nokia    generate    suffering    act    paper    executives    serval    trillio    completing    plan    turn    optimizes    recommendations    aifa    andrea    therapy    alarm    difficulties    diseases    market    founders    abroad    500    connections    50    startup    ten    sure    press    health    sound    gaggi    device    executing    italy    lifestyle    pilot    la    burdens    launching    italian    mobile    adherence    alerts    patient    showing    right    team    family    17m    person    billion    deaths    brianza    therapeutic    200    150    sends    medication    diet    connected    selling    app    turnover    innovative    time    000    small    corresponds    agreed   

Project "TRILLIO" data sheet

The following table provides information about the project.

Coordinator
LA COMANDA SRL 

Organization address
address: VIA BARTOLOMEO EUSTACHI 52
city: MILANO
postcode: 20129
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Project website http://www.trillio.org/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-05-01   to  2018-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LA COMANDA SRL IT (MILANO) coordinator 50˙000.00

Map

 Project objective

'Therapeutic adherence is defined as “the extent to which a person’s behaviour – taking medication, following a diet, and/or executing lifestyle changes, corresponds with agreed recommendations from a health care provider”. It is estimated that each year the poor adherence to medical treatments in Europe causes about 200,000 deaths and burdens on health expenditure up to 80 billion euro a year (AIFA source). TRILLIO is a therapeutic adherence device really similar to an “alarm clock”, thus really familiar for elderly. The TRILLIO device is provided with an app that optimizes the connections among various players and organizations who share a common goal: make sure a patient follows his or her pharmaceutical treatment plan. When it's time to take a drug, TRILLIO alerts the user with a sound and a visual alarm, while showing all the relevant information on its 2.7' e-paper display. If the user doesn't press the button on the device to turn off the alarm within ten minutes, TRILLIO automatically sends a notification to any family member connected to the system. TRILLIO has been already tested in Italy and received serval endorsement by organisations in Italy and abroad. We are a targeting and overall population composed by 150.000.000 European that are suffering from Chronic diseases, 50% of them have difficulties in following a therapy: we are addressing 0,2% of this market and we are aiming at selling 112.000 devices by 2023, that will generate 17M€ turnover. The Feasibility study will have the purpose to support us in completing the market analysis, in launching a small pilot (i.e. 500/1.000 users), in identifying suitable partners in Europe for wide demo site (i.e. hospitals) and in identifying the right partners for distributing TRILLIO in Europe. TRILLIO is brought on the market by LA COMANDA, an Italian startup established under the Italian act for innovative startup, whose founders are Carlo Brianza and Andrea Gaggi, former executives of Nokia mobile team. '

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "TRILLIO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "TRILLIO" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

CAARESYS (2019)

CAARESYS: vehicle passenger monitoring system based on contactless low emission radio frequency radar.

Read More  

RoboSynFarm (2019)

Robotic Synthesis Farm

Read More  

APS (2019)

On-site and On-demand Flexible Packaging System

Read More